AlphaYouDP
Congress trade
Sen. David Perdue (R-GA) bought $100K-$250K of Merck & Co., Inc. (MRK) stock
David Perdue, U.S. Senator (R-GA), disclosed a purchase of Merck & Co., Inc. (MRK) stock worth $100K-$250K in a STOCK Act filing on Feb 1, 2018.
The trade happened on Jan 16, 2018, 16 days before it was made public.
MRK has moved +143.6% since the trade date, from $59.23 to $144.30 (Oct 2, 2026 close).
- Traded
- Jan 16, 2018
- Disclosed
- Feb 1, 2018
- Filing delay
- 16 days
- Price since
- +143.6%
- Source
- STOCK Act disclosure
Other trades in this disclosure (42)
- SellSPY$500K-$1MFeb 1, 2018
- BuyDISCA$100K-$250KFeb 1, 2018
- BuyFDC$100K-$250KFeb 1, 2018
- BuyFEYE$100K-$250KFeb 1, 2018
- BuyHBI$100K-$250KFeb 1, 2018
- BuyMOS$100K-$250KFeb 1, 2018
- BuyPG$50K-$100KFeb 1, 2018
- BuyCOP$15K-$50KFeb 1, 2018
- SellENB$15K-$50KFeb 1, 2018
- SellSPY$15K-$50KFeb 1, 2018
- BuyXOM$15K-$50KFeb 1, 2018
- BuyAVP$1K-$15KFeb 1, 2018
- BuyCBS$1K-$15KFeb 1, 2018
- BuyCBS$1K-$15KFeb 1, 2018
- BuyCBS$1K-$15KFeb 1, 2018
- SellCSCO$1K-$15KFeb 1, 2018
- BuyDVN$1K-$15KFeb 1, 2018
- SellENB$1K-$15KFeb 1, 2018
- SellENB$1K-$15KFeb 1, 2018
- SellFOXA$1K-$15KFeb 1, 2018
More MRK insider and Congress trades
From a public STOCK Act disclosure, linked above. Not investment advice, and not a recommendation to buy or sell.